Viewing Study NCT04956432


Ignite Creation Date: 2025-12-24 @ 9:45 PM
Ignite Modification Date: 2025-12-25 @ 7:25 PM
Study NCT ID: NCT04956432
Status: COMPLETED
Last Update Posted: 2025-01-24
First Post: 2021-07-07
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Multicentre, Randomized, Double-blind, Allopurinol Controlled Study to Evaluate the Efficacy and Safety of SHR4640 in Subjects With Gout
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-06-15
Start Date Type: ACTUAL
Primary Completion Date: 2023-12-13
Primary Completion Date Type: ACTUAL
Completion Date: 2024-08-23
Completion Date Type: ACTUAL
First Submit Date: 2021-07-07
First Submit QC Date: None
Study First Post Date: 2021-07-09
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-01-23
Last Update Post Date: 2025-01-24
Last Update Post Date Type: ACTUAL